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Summary of the master’s thesis    
Improved survivor rates among breast cancer patients and increased amount of 
patients living with side-effects after treatment, have led to increased focus on quality of life 
(QoL). Aspects like body image, sexual function, future perspective and social function have 
been seen in association with QoL, in breast cancer patients. The relationship between QoL 
and aspects like body image, sexual function, social function and future perspective can be 
highlighted by theories like the biopsychosocial model of health and illness, and the identity 
theory. Age-differences in aspects of HRQoL are mentioned as essential, and are highlighted 
as an important suggestion for further research among breast cancer patients. The present 
master’s thesis report significant lower body image in younger women (≤ 50 years) than 
among older women (>50 years) treated for breast cancer. Social function and sexual function 
were significantly associated with higher levels of QoL among younger women. In older 
women, social function, sexual function and future perspective were significantly associated 
to QoL. The results highlights the importance of enhancing social and sexual functioning 
among women treated for breast cancer.  
 
Norsk sammendrag av masteroppgaven  
Økende overlevelsesrate blant brystkreft pasienter og økt antall pasienter som lever 
med bivirkninger etter behandling, har ført til et økende fokus på livskvalitet. Aspekter som 
kroppsbilde, seksuell funksjon, fremtidsperspektiv og sosial funksjon har blitt relatert til 
livskvalitet blant brystkreft pasienter. Forholdet mellom livskvalitet og aspekter som 
kroppsbilde, seksuell funksjon, sosial funksjon og fremtidsperspektiv kan belyses av teorier 
som den biopsykososiale modellen for helse og sykdom og identitetsteorien. Aldersforskjell 
blant brystkreft pasienter nevnes som essensielt når det gjelder aspekter av helse- relatert 
livskvalitet, og har blitt foreslått som tema for fremtidig forskning. Den aktuelle 
masteroppgaven rapporterer at yngre kvinner (≤ 50 år) har signifikant lavere kroppsbilde enn 
eldre kvinner (>50 år) som har fått behandling mot brystkreft. Blant yngre kvinner var sosial 
og seksuell funksjon assosiert med signifikant bedre livskvalitet. Blant de eldre kvinnene, var 
det signifikante assosiasjoner mellom sosial funksjon, seksuell funksjon, fremtidsperspektiv 
og bedre livskvalitet. Disse resultatene belyser viktigheten av å bedre sosial og seksuell 
funksjon blant kvinner som har fått behandling mot brystkreft. 
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Main introduction 
The present master’s thesis, “Health Related Quality of Life in younger and older 
women treated for breast cancer in Norway,” consists of two articles with different structures. 
The two articles are related to each other, and must be read in the given order. The APA 
(American Psychological Association) is the reference style in both articles. 
The first article, “Aspects of breast cancer, Quality of Life (QoL) and Health-Related 
Quality of Life (HRQoL) - A theoretical background,” provides the theoretical background of 
both articles. Since this article provides an introduction of the theoretical aspects and clarifies 
the concepts this article must be read first. Relevant articles and earlier research were mainly 
collected from databases such as Pub Med and Science Direct. The most commonly used key 
words to locate relevant material were breast cancer, quality of life, health-related quality of 
life, age-related differences, sexuality, body image, social function, future perspective, 
biopsychosocial model, identity theory and treatment in breast cancer. In short, the first article 
is chiefly a literature review and therefore provides the basis and background for the second 
article, which is empirical in nature.        
  The second article, “Differences in HRQoL between younger and older women treated 
for breast cancer: Associations between social function, future perspective, body image, 
sexual function and QoL,” is an empirical study. This article is based upon data from a larger, 
prospective longitudinal study that investigates the side effects and health-related quality of 
life (HRQoL) after radiotherapy (RT) in breast cancer patients. The second article uses the 
structure and instructions from Psycho-Oncology as a guideline for its direction and 
approximate scope. 
At the end of this paper are some appendixes. These are the EORTC QLQ-C30 
Questionnaire (Appendix 1), the EORTC QLQ-BR23 Questionnaire (Appendix 2), 
Questionnaire for Background Information (Appendix 3) and a Certification from The 
Regional Committees for Medical Research Ethics (Appendix 4).   
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Aspects of breast cancer, 
Quality of Life (QoL) and Health-Related Quality of Life (HRQoL) -     
A theoretical background 
 
Katrine Salberg Jensen 
Department of Social Work and Health Science 
Norwegian University of Science and Technology (NTNU) 
 
 
Abstract:  
Today’s improved survivor rates among breast cancer patients leads to several challenges. 
Many breast cancer survivors are living with different side effects which might affect their 
QoL. Several aspects like body image, sexual function, future perspective and social function 
have been seen in association with QoL. Previous research also indicates that body image and 
sexual problems are influenced by breast cancer treatments such as type of surgery and 
chemotherapy. The relationship between QoL and aspects like body image, sexual function, 
social function and future perspective can be highlighted by theories such as the 
biopsychosocial model of health and illness and the identity theory. Age differences in aspects 
of HRQoL are mentioned as essential and are highlighted as an important suggestion for 
further research among breast cancer patients.  
 
Key words: Breast cancer, breast cancer treatment, Quality of Life, Health-related Quality of  
          Life, body image, sexual function, social function, future perspective, age-related  
          differences, biopsychosocial model, identity theory.  
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1. Breast cancer 
Today, breast cancer is the most common cancer in women worldwide (World Health 
Organization, 2012). In Norway, 2745 new cases of breast cancer were recorded in 2009 
(Cancer Registry of Norway, 2011). About 80% of those 2745 affected by breast cancer are 
over 50 years of age, and the risk of getting this disease increase with age (The Norwegian 
Cancer Society, 2011). Rapid advancements in breast cancer treatments and mammography 
screening play an important role in the increasing rates of survival (Holleczek, Arndt, 
Stegmaier & Brenner, 2011). Nevertheless, women who do survive breast cancer meet 
medical, physical and psychosocial challenges (Dizon, 2009). The HRQoL includes the 
subjective impact of the disease as well as the disease’s impairments and their treatments 
(Carr, Gibson and Robinson, 2001). The developments in treatments have consequently led to 
an increasing focus on quality of life issues among breast cancer patients and in research 
(Montazeri et al., 2008).  
Breast cancer is a malignant tumor that originates from the breast tissue or lymph 
nodes around the breast. It is not known why some individuals develop breast cancer and 
some do not, but we do know that about 5% of all reported breast cancers are hereditary (The 
Norwegian Cancer Society, 2011). From the beginning of the year 2005 trough the year 2009, 
the five-year survival rate among breast cancer patients in Norway was 88.3% in total (Cancer 
Registry of Norway, 2011).  
The breasts mainly consist of fat tissue, and this fat surrounds twelve to twenty 
glandules in protective tissue (Kåresen, Schlichting & Wist, 1998). The breast tissue changes 
in the woman’s mid-thirties, when the glandular tissue changes to fat tissue (The Norwegian 
Cancer Society, 2011; Kåresen et al., 1998). As a result, the breasts become less firm the 
older one grows (Kåresen et al., 1998). Some may fear this transformation, but it is a normal 
change. Similarly, not all tumors in the breast are malignant; some of them are part of the 
natural transformation and are benign (The Norwegian Cancer Society, 2011). The 
significance of the breasts is mainly to produce milk during pregnancy, but they are also 
meaningful for women’s self-image and appear as a symbol of femininity and sexuality 
(Kåresen et al., 1998).  
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2. Treatment of breast cancer 
The standard treatment of breast cancer patients is surgery followed by different 
combinations of adjuvant (additional) treatments like chemotherapy, radiotherapy and 
hormone therapy (NBCG, 2012; Norwegian Directorate of Health, 2007). There are different 
kinds of surgery, and the most common are mastectomy or breast conserving surgery (King, 
Kenny, Shiell, Hall & Boyages, 2000). The aims of surgery are to eradicate the tumor and its 
prospective local extension, to control the disease and to increase the patient’s survival rate. 
Breast conserving surgery removes only the tumor and a rim of normal breast tissue around 
the tumor. This type of surgery can be done if the mammography can locate clear margins 
around the tumor (NBCG, 2012). Mastectomy is a total excision of the breast parenchyma. 
This surgery is for patients with tumors in ill-defined margins, with tumors that widely extend 
within the breast or with tumors that involve the overlaying skin or nipple (NBCG, 2012; 
NHMRC, 2001).  
Depending on the stage of the disease as well as the patient’s age and the hormonal 
status of the tumor, some patients need additional (adjuvant) treatments with chemotherapy, 
radiotherapy and/or hormones (NBCG, 2012). Adjuvant treatments are shown to reduce the 
risk of recurrence and thereby improve survival in breast cancer patients (Montazeri, 2008). 
Results show that every year in Norway, chemotherapy reduces the death rate by 38% 
among patients under 50 years old and 20% among those older than 50 years. The age of the 
patient, the hormone’s status, the risk for recurrence, the side effects and the actability are 
important when assessing the need of systemic adjuvant treatment. Chemotherapy doses are 
calculated from the patient’s body surface, and the treatment can be given every week or with 
three weeks spaces. The most common side effects of chemotherapy are hair loss and nausea, 
which stop after the end of the treatment (NBCG, 2012). 
Radiotherapy usually starts about three to eight weeks after surgery, depending on 
whether the patient has been scheduled for chemotherapy treatment after the surgery. If 
chemotherapy treatment is not necessary, then radiotherapy should start about six to eight 
weeks after surgery. If chemotherapy is performed, then radiotherapy should start about three 
to four weeks after the end of the chemotherapy treatment. Radiotherapy is often administered 
five days per week and usually over a period of five weeks. The side effects of radiotherapy 
after breast radiation could be lymphoedema, impaired shoulder mobility and cardiac and 
lung damage, which may affect the patient’s quality of life (Senkus-Konefka & Jassem, 
2006).  
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The function and growth of the breast tissue depends on the interaction between several 
hormones. A tumor is also sensitive to hormones, which is why hormone therapy is used as 
adjuvant treatment. In hormone treatment, the grade of the estrogen and progesterone 
receptors in the tumor predicts the tumor’s response to the hormone treatment (NBCG, 2012). 
Hormone therapy may cause chemically induced menopause (Emilee, Ussher & Perz, 2010). 
Treatment of breast cancer is associated with several side effects like fatigue, pain and 
those affecting quality of life (Montazeri, 2008). The most frequently reported side effect is 
fatigue. Fatigue is a nonspecific, multidimensional construct that involve tiredness, weakness 
and lack of energy, and can often last for years following the end of the treatment (Bower et 
al., 2000). Fatigue is known to influence many dimensions of life, including social function 
and sexual function (Bower et al., 2000; Henson, 2002). The choice of treatment and the type 
of diagnosis may affect a woman’s body image, sexuality and well-being (Kissane, White, 
Cooper & Vitetta, 2004). The treatments may cause the patient to experience symptoms, even 
when the adjuvant treatments extend survival (Miaskowski et al., 2006). These experienced 
symptoms can lead to a lower score on quality of life (Ganz et al., 2002; Ganz et al., 2004).  
3. Quality of Life (QoL) 
The World Health Organization defines Quality if life (QoL) as “an individual’s 
perception of their position in life in the context of the culture and value systems in which 
they live and in relation to their goals, expectations, standards and concerns” (World Health 
Organization, 1997, p. 1). This definition enunciates that QoL is subjective, and can only be 
measured by the individual (Van der Steeg, De Vries & Roukema, 2004). QoL has no 
universal definition; instead, the concept is complex, broad and multidimensional (CDC, 
2000; Eriksson, 2007). QoL conveys an overall sense of well-being, happiness and 
satisfaction with life as whole and includes subjective evaluations of both positive and 
negative aspects of life (CDC, 2000; The WHO QOL Group, 1998). It is challenging to 
measure QoL because the term has different meanings for nearly everyone. It includes diverse 
domains such as health, jobs, housing, schools, culture, spirituality and values (CDC, 2000). 
To illustrate the complexity of QoL, a figure is included (Figure 1).  
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Figure 1. Illustration of the multidimensional concept Quality of Life (QoL). 
 
 
 
 
 
 
 
 
 
 
Reference: CDC, 2000, p.6                
Figure 1 illustrates the complexity and the multidimensionality of the QoL concept. As 
shown in the illustration, QoL includes aspects such as health, function and health related 
quality of life (HRQoL), and these aspects include several sub-categories as well. The figure 
attempts to show that all these factors are separate aspects, but at the same time a part of the 
broad QoL term. This article will explain one of these aspects and its sub-categories; the 
health related quality of life (HRQoL), more thoroughly in the following section.   
4. Health-Related Quality of Life (HRQoL) 
To handle the complexity of QoL, researchers have developed helpful techniques to 
conceptualize and measure its different domains. Health-related quality of life (HRQoL) 
encompasses aspects of overall QoL that can be apparently shown to affect both physical and 
mental health (CDC, 2000). To distinguish between the more general term QoL and the 
requirement of clinical medicine and clinical trials, the term HRQoL is used (Fayers & 
Machin, 2000). HRQoL is described as the space between a person’s expectations of health 
and the person’s experience of it, which varies among individuals. HRQoL concerns the 
subjective impact of the disease, its impairments and their treatments (Carr et al., 2001). The 
term HRQoL was meant to narrow the practitioners’ focus on the effects of health, illness and 
treatment on QoL (Ferrans, Zerwic, Wilbur & Larson, 2005). HRQoL is an extensive concept, 
and includes factors like physical, emotional, sexual, social and cognitive functions, 
symptoms of disease and treatment, health risks, functional status, social support and 
socioeconomic status. All of these factors are considered by and from the perspective of the 
patient (Bottomley & Therasse, 2002). HRQoL measures have become important components 
of health observations both in the general population and among the ill (CDC, 2000).  
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5. Assessments of HRQoL 
Although HRQoL is complex, diverse measuring instruments for this aspect exist, 
including questionnaires that are generic, disease-specific and domain-specific. Generic 
measures are broad measures of health status, and should encompass the dimensions of 
physical, mental and social health. Generic measures are often used to compare disease 
groups within and between specialties. The most popular generic measure is SF-36. However, 
generic measures are often supplemented with disease-specific measures (Bowling, 2001; 
CDC, 2000). Disease-specific measurements are clinically significant to specific conditions 
and diseases, so they are used when disease or condition-related attributes need to be 
assessed. A popular disease-specific measurement is the EORTC QLQ-C30. Finally, some 
researchers supplement their disease-specific measures with domain-specific measures. 
Domain-specific measures are used when the area is of particular interest to the researcher 
and when disease-specific or generic measurements selected for use, ignore the actual 
domain. Domain-specific measurements are specialized scales measuring specific domains, 
but the area of interest will vary according to how the condition and its treatment affect the 
patient (Bowling, 2001).  
Several trends in health care have resulted in the development of pragmatic techniques 
that have helped to conceptualize and measure HRQoL more effectively (Fitzpatrick, Davey, 
Buxton & Jones, 1998). Information about HRQoL has become important and useful to both 
patients and physicians when they make decisions about treatments for serious diseases like 
cancer (Whelan & Pritchard, 2006). This article will delve into a closer look at the cancer-
specific EORTC QLQ-C30 questionnaire. 
The European Organization for Research and Treatment of Cancer (EORTC) was 
founded in 1962, and the aims of the organization are to conduct, develop, coordinate and 
stimulate cancer research in Europe. In 1980, the EORTC Quality of Life Group was created, 
which initiated a research program to develop and evaluate the QoL of patients participating 
in cancer trials. Further, this led to the development of the EORTC QLQ-C30, which is a QoL 
instrument for cancer patients (Aaronson et al., 1993). The EORTC questionnaires are used in 
several studies and are one of the most acceptable tools for measuring QoL in Europe. 
EORTC have operationalized the HRQoL in terms of functional status, cancer and treatment 
by pinpointing specific symptoms, the status of psychological, social and financial well-being 
and the global health status (Aaronson et al., 1993; Montazeri, 2008).  
EORTC QLQ-C30 is a disease-specific self-assessment instrument and a core- 
questionnaire that contains of 30 items (Aaronson et al., 1993). QLQ-C30 is composed of 
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both multi-item scales and single-item measures. The questionnaire contains five functional 
scales (physical, role, emotional, cognitive and social functioning), three symptom scales 
(fatigue, pain and nausea and vomiting), six single items (dyspnoea, insomnia, appetite loss, 
constipation, diarrhoea, and financial difficulties) and a global health status/ QoL scale 
(Aaronson et al., 1993). Hereafter, this paper will refer to the global health status/QoL scale 
as just QoL. 
One of the EORTC’s essential functions has been the development and use of 
supplementary disease- or treatment specific questionnaire modules, which can provide 
relatively detailed information of specific patient groups. These modules are often used in 
addition to the EORTC QLQ-C30, and they cover general aspects of HRQoL in the cancer 
population. One of these specific patient groups is comprised of breast cancer patients. 
EORTC have made a disease- specific module questionnaire for breast cancer, called 
the EORTC Quality of Life Questionnaire Breast Cancer 23 Items (QLQ-BR23), which asks 
23 questions. These questions fall under five multi-item scales that assess systemic therapy 
side effects (surgery, chemotherapy, radiotherapy and hormonal treatment), arm symptoms, 
breast symptoms (symptom scales), body image and sexual functioning (function scales). In 
addition, three single items assess sexual enjoyment, hair loss and future perspective 
(Aaronson et al., 1993). The EORTC QLQ-C30 and QLQ-BR23 questionnaires are both 
validated in Norwegian (EORTC group for research into Quality of Life, 2011). 
As explained, HRQoL refers to several aspects of health, both physical and mental 
(Bjornson & McLaughlin, 2001; CDC, 2000). To illustrate how EORTC have operationalized 
HRQoL in breast cancer patients, this article includes two figures (Figure 2 and Figure 3). 
These figures illustrate how this article understands and interprets the complexity of HRQoL 
according to EORTC’s questionnaires (QLQ-C30 and QLQ-BR23). 
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Social function  
Emotional function 
 Role function 
 Physical  function 
Cognitive function 
Syptoms like: 
fatigue 
nausea and vomiting 
pain 
 
 
Body Image 
Sexual function 
Sexual enjoyment 
Future perspective  
Systemic therapy 
Breast symptoms 
Arm symptoms 
Upset by hairloss 
Overall 
QoL 
Figure 2. General model with all variables. Associations between overall QoL and HRQoL 
aspects in accordance to EORTC questionnaires QLQ-C30 and QLQ-BR23 
  
 
 
 
 
 
 
 
 
 
 
 
     
 
   Figure 2 shows a general model with all EORTC-variables from both QLQ-C30 and 
QLQ-BR23. This model illustrates that all of the domains in the first circle from the QLQ-
C30 questionnaire (social function, emotional function, role function, physical function, 
cognitive function, pain and symptoms like fatigue, nausea and vomiting) and the domains in 
the second circle from the QLQ-BR23 questionnaire (body image, sexual function, sexual 
enjoyment, future perspective, systemic therapy, breast symptoms, arm symptoms and feeling 
upset by hair loss) are independent domains that are separate from the overall QoL, yet they 
contribute to the larger concept, overall QoL.  
These several aspects related to breast cancer and QoL can be interpreted and 
understood more thoroughly trough theories. Among the extant theories, the biopsychosocial 
model of health and illness and the identity theory may explain some relations in breast 
cancer.  
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6. The biopsychosocial model for health and illness and breast cancer 
The biopsychosocial model for health and illness came as a development of the 
biomedical model in the 1970’s. Numerous researchers criticized the biomedical model for its 
simplistic, causal thinking and for its other insufficiencies (Espnes & Smedslund, 2009). In 
response to these criticisms, Georg Engel created the new and developed biopsychosocial 
model. He claimed that the biomedical model is dualistic, as it assesses body and mind 
separately. In the biopsychosocial model, the dualistic aspect has been transformed, or is at 
least less visible, and a more holistic view comes through. Engel explained the 
biopsychosocial model as a dynamic and interactional model with a dualistic view of human 
experience in which mind and body have mutual influence (Borrell-Carriò, Suchman & 
Epstein, 2004). 
The biopsychosocial model provides a holistic view of health and is influenced by 
biological, social and psychological factors. It relies on the assumption that every process in 
the body is affected by an interaction between biological, social and psychological factors. 
For example, when people become sick, their psychological and social factors are affected as 
well as the physical parts of their body (Espnes & Smedslund, 2009). Stress, attachment 
ability and performance and coping strategies, are portions of this biopsychosocial 
perspective. In addition, previous knowledge of social factors, work, status, economics, 
location, network and support affect the researcher’s understanding of illness and behavior 
(Stubhaug, 2005). 
One can understand and explain the different aspects of breast cancer by applying the 
biopsychosocial model and its view of health and illness (Wong-Kim & Bloom, 2004). Breast 
cancer survivors may face many concerns that span the areas of medicine, psychology, 
sexuality and physical status (Dizon, 2009). For example, surgical removal of the breast is 
invasive and has therefore been shown to affect the QoL. Specially, associations between 
having a mastectomy and psychological distress, depression, anxiety and diminished body 
image have been shown (Emilee et al., 2010; King et al., 2000; Moyer, 1997). The link 
between having a mastectomy and psychological distress, body image problems, depression 
and anxiety can indicate the essence of the biopsychosocial model (i.e., body and mind are 
connected). Also, sexual dysfunction after treatment for breast cancer includes physical, 
psychological, inter-relational and physiological aspects (Dizon, 2009), and can therefore be 
seen in light of the biopsychosocial model. Biological and physical changes in sexuality may 
depend on the woman’s psychological health and how she perceives herself (Hordern, 2000). 
Research also found that self-esteem and body image problems significantly affect the QoL 
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among young women with breast cancer (Wong-Kim & Bloom, 2004). In accordance to this, 
a link between body image and this image’s effect on QoL can be seen. The identity theory 
may be used as a framework to understand different processes among people and to see how 
illness-related identities like breast cancer may affect the self (Deimling, Bowman & Wagner, 
2007).  
7. Identity theory and breast cancer 
The identity theory, originally formulated by Stryker, is a micro-sociological theory 
that explains the individual’s role-related behaviors. The theory explains a multifaceted and 
dynamic view of the self and of the relationship between the individual’s behavior, the 
surrounding social structure and society. Society has an effect on one’s social behavior and on 
one’s very self when one is among people. The self is described as a social construct that 
emerges from one’s multiple roles in society. The theory assumes that people occupy different 
roles, which are called role identities. These role identities may include the role of being a 
mother, a wife, a daughter, a blood donor and a social worker. In addition, people may occupy 
self-defining roles like gender, race and ethnicity while in society. Poor role performance may 
result in changes in the self and may produce symptoms of psychological distress (Hogg, 
Terry & White, 1995). 
Identity theory may be used as a framework to understand different processes among 
people and to see how illness-related identities may affect the self. Stressors in life, such as 
life-threatening illness, may result in changes to personal identity. These changes can further 
alter aspects of a person’s self. Different kinds of specific identities that people feel are 
important when they describe who they are may be disrupted if stressors like illness appear. 
The identity factors that can be disrupted include one’s career, professional or family 
identities. Illness identities may replace the individual’s real and specific identities (Deimling 
et al., 2007). 
Cancer is one of these life-threatening illnesses that may appear at any point in a 
person’s life. Cancer, as an illness-identity, can replace the original and primary identities of a 
person. One of the cancer types that might heavily affect identity is breast cancer. Breast 
cancer is called a sex-specific cancer, so it may affect important elements of the self that 
pertain to gender. The disease can have an impact on how a woman performs her roles, such 
as being a mother, performing parental care, engaging in spousal intimacy or meeting 
expectations at work (Deimling et al., 2007). 
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Social function and other aspects of QoL in breast cancer patients may be seen in 
accordance to the identity theory. The identity theory explains that there is a relationship 
between an individual’s behavior and society’s structure and members. Given this theory’s 
assumption that society has an effect on social behavior and the self (Hogg et al., 1995), one 
can view social function among breast cancer patients as a part of the identity theory. 
Problems with social function among breast cancer patients may occur from the relationship 
between individual behavior and the social structure and society. Rosedale (2009) explains 
that women deal with various social challenges after breast cancer, such as the pressure to 
return to normal or the pressure to maintain a heroic survivor narrative. These problems and 
worries may explain why some women become less social after breast cancer treatment, and 
some even do not return to work. As the identity theory asserts, society’s expectations are 
affecting social behavior (Hogg et al., 1995).  
Aspects of body image and self-esteem may also be seen in accordance to the identity 
theory. In accordance to role identities, poor role performance may affect the self and some 
may produce symptoms of psychological distress (Hogg et al., 1995). Earlier research found 
that the breasts are significant to women’s self-image, and are a symbol of femininity and 
sexuality (Kåresen et al., 1998); therefore, breast cancer may arouse feelings and behavior 
from women that can be explained with the identity theory. For example, a woman treated for 
breast cancer may feel different from her original identity, because the illness-identity has 
taken over as her main identity (Deimling et al., 2007). The cancer disease can make women 
feel less feminine when they lose one or both breasts. The cancer disease can also affect 
important elements of the self pertaining to gender and this disease can have an impact on 
how a woman performs her roles, such as being a mother, a spouse or a professional 
(Deimling et al.,  2007). While coping with breast cancer and the side effects of treatment, 
women may feel that they cannot fill these roles any longer and too many problems are 
occurring in their lives. The identity theory can illustrate how the aspects of breast cancer may 
affect the life and daily roles of a woman. 
The relationship among QoL and body image, sexuality, social function and other 
aspects in breast cancer, can be explained with the thoughts behind the biopsychosocial model 
of health and illness and the identity theory. Earlier research has documented that several 
aspects affects QoL after a breast cancer diagnosis. Changes in physical, psychological, 
functional, social and sexual aspects affect one’s QoL (Henson, 2002). For an illustration of 
how the selected aspects from the EORTC questionnaires are related to QoL, see Figure 3. 
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Social function 
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Sexual function 
Future 
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Overall 
QoL 
Figure 3. Specific model for the chosen variables used in the next empirical article.  
Associations between overall QoL and HRQoL aspects in accordance to EORTC 
questionnaires QLQ-C30 and QLQ-BR23. 
 
 
    
 
 
 
 
 
 
 
 
Figure 3 demonstrates that social function, body image, sexual function and future 
perspective are all independent domains separated from the overall QoL, but also makes a part 
of the lager overall QoL concept. The figure also illustrates how specific variables used and 
analyzed in this paper are related to overall QoL. Next, this paper provides the explanations 
and background information of each aspect.  
 
  
 15 
 
8. Body image and sexuality in breast cancer  
Body image and sexuality are both aspects of the human behavior (Fobair et al., 2006), 
and breast cancer may affect them (Sheppard & Ely, 2008). Women’s breasts play an 
important role in their feminine identity and have extensive meaning for their body 
(Montazeri, 2008; Pikler & Winterowd, 2003). Subjects related to the breasts are sexuality, 
motherhood, attractiveness, femininity and womanhood (Pikler & Winterowd, 2003).  
Many definitions of the term body image have been presented, yet the term still lacks a 
clear definition (White, 2000). Body image is, for example, defined as “a person’s 
perceptions, thoughts, and feelings about his or her body” (Grogan, 2008, p. 3). In the context 
of cancer, body image often refers to psychological aspects such as sexuality, self-esteem and 
stigma. How a woman experiences her body is subjective and is often a result of her thoughts, 
perceptions and feelings (White, 2000). For example, Pikler and Winterowd (2003) claim that 
women with better body image cope better with breast cancer.  
Problems with body image and sexuality during the first year of survivorship appear to 
be influenced by the type of cancer treatment the patient underwent (Fobair et al., 2006) as 
well as the type of surgery. Women who received breast conserving surgery reported better 
body image than women treated with mastectomy (Curran et al., 1998; Figueiredo, Cullen, 
Hwang, Rowland & Mandelblatt, 2004; Ganz, Cosacarelli Shag, Lee, Polinsky & Tan, 1992; 
Hopwood, Haviland, Mills, Sumo & Bliss, 2007; Kenny et al., 2000; King, Kenny, Shiell, 
Hall & Boyages, 2000; Montazeri, 2008). On the other hand, Shimozuma, Ganz, Petersen and 
Hirji (1999) found no relationship between type of surgery and QoL aspects. Thus, 
differences in research results do exist, and both surgery options have approximately the same 
survival rates (King et al., 2000). The practitioner’s choice between mastectomy and breast 
conserving surgery may depend on differences in QoL and other elements of the patient’s 
preferences (Kenny et al., 2000). 
After diagnosis of breast cancer, the patient may undergo changes in sexuality and 
intimacy depending on the woman’s psychological health, how she views herself, her 
sexuality before the diagnosis and where she is in her life cycle (Hordern, 2000). Sexuality 
encompasses biological, psychologic, physical, inter-relational and physiologic aspects, and 
sexual function is defined as “a range of solo and partnered forms of sexual expression” 
(Dizon, 2009; DeLamater & Karraker, 2009). Impaired sexual functioning is associated with 
reduced QoL among women with breast cancer (Montazeri, 2008). Sexual dysfunction affects 
about 90% of women diagnosed with and treated for breast cancer, and it can come in the 
form of physical, psychological, inter-relational and physiological dysfunction (Dizon, 2009). 
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Problems and physical changes in sexual function after breast cancer may concern disruption 
of sexual arousal, orgasm, sexual desire and pleasure. These changes could be related to the 
side effects of chemotherapy, hormonal therapy (chemically induced menopause) and breast 
surgery (Emilee et al., 2010). The types of sexual side effects and other problems related to 
breast cancer may depend on the age of the patient (Andt et al., 2004; King et al., 2000). 
Research suggests that it’s differences between younger and older women and their 
experience and scores in aspects like body image and sexual function (Andt et al., 2004; King 
et al., 2000). Interestingly, King et al. (2000), found that older women on average had better 
body image than younger women and that younger women were more afraid of disease 
recurrence than older women. They also presented that older women had a slightly better 
average QoL than younger women had and that the breasts were less important to the older 
women’s feelings of attractiveness and femininity. Likewise, Hopwood et al. (2007) found 
that younger women (< 50 years) had worse body image than older women had. In contrast, 
Arndt et al. (2004) reported that younger women had better QoL than older women had. They 
also found that older breast cancer patients tended to report better role, emotional, cognitive 
and social functioning than younger women with breast cancer reported. According to 
Watters, Yau, O’Rourke, Tomiak & Gertler (2003), sexual function at baseline was 
significantly better among young women, and future perspective was significantly better 
among older women. The improvement in future perspective at follow-up was significantly 
greater in young women, and the decline in body image by the completion of chemotherapy 
tended to be more marked in young women. Furthermore, Montazeri (2008) explained that 
sexual function is an area that needs more attention, especially for younger breast cancer 
survivors. He also reported that younger women with breast cancer may need interventions 
that target their needs in problems with relationships, menopausal problems, sexual 
functioning and body image. Wenzel et al. (1999) presented results that showed no significant 
differences in sexual dysfunction or body image among younger and older breast cancer 
patients. As shown, there are several examples that can highlight age as an important aspect to 
be included in any discussion about QoL among women diagnosed with breast cancer. Arndt 
et al. (2004) add that social function and future perspective are two other aspects in QoL. 
  
 17 
 
9. Social functioning and future perspective in breast cancer   
As the previous section mentioned, the term QoL refers to a multidimensional concept 
that includes dimensions like physical, emotional and social functioning (Arndt et al., 2004). 
Two of the most fundamental human motivations are the need to form interpersonal 
connections and the need to function in society (Preston, 2010). Among other explanations, 
has social function been explained as normative behavior in a social situation (Blakely & 
Dziadosz, 2007). Tyrer and Casey (1993) specifically define social function as “the level at 
which an individual functions in his or her social context, such function ranging between self 
preservation and basic living skills to the relationship with others in society” (p. 8).  
Women have many roles in society that may include employer, parent, friend and 
spouse. When a woman discovers that she is ill, such as when she receives a breast cancer 
diagnosis, many experience impairment in several areas of her life, including social 
functioning. Women’s social functioning roles that may change after breast cancer diagnosis 
include household, family, social and community, self-care and occupational activities 
(Preston, 2010). Appearance-related breast cancer treatment can lead to social changes that 
are potentially disrupting. Visible problems among breast cancer patients may lead to 
avoidance of social situations, which can lead to other problems (Harcourt & Frith, 2008). 
Earlier research has also found a connection between breast cancer and social 
function. According to Watters et al. (2003), physical, role and social functions may decrease 
during breast cancer treatments. A correlation between type of surgery and social function has 
also been shown. It is assumed that mastectomy patients will have an improved social 
function domain score (Munshi et al., 2010). The woman’s social function in terms of her 
partner can also be affected by breast cancer. The changes in sexuality that might result from 
breast cancer seem to influence the woman’s social function with her current partner. 
Sexuality is a main aspect when it comes to relationships between a women and her husband, 
and it can affect social function and QoL in connection with the disease and treatment 
(Manganiello, Hoga, Reberte, Miranda & Rocha, 2011). Furthermore, social function is 
linked to social support and integration in breast cancer. For example, women who were well 
integrated socially, before their breast cancer treatment tend to report better role function and 
vitality than less socially integrated women (Mandelblatt, Figueiredo & Cullen, 2003). 
The future has always had a special place in the human mind. Numerous individuals 
desire a forecast of events that will occur. Cognitive abilities like abstract imagination, logical 
reasoning and induction can be necessary to forecast the future (McLean & Hurd, 2011). 
Future perspective can lead to considerations among breast cancer patients. Different kinds of 
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considerations may appear in accordance to thoughts about the future and the future 
perspective, such as fertility considerations. About 25% of diagnosed women worldwide will 
be diagnosed in their reproductive years, which make their choice of breast cancer treatment 
difficult to resolve (Dizon, 2009). Research has also shown that reported future perspective 
among breast cancer patients, can be seen in relationship with type of surgical treatment and 
adjuvant treatment. Future perspective domains are reported to be significantly better in 
patients treated with breast conserving surgery than in patients treated with mastectomy 
(Munshi et al., 2010). There are also other worries connected to the future perspectives of 
women with breast cancer, especially among younger women. These worries may be concerns 
about survival, concerns about premature menopause (which shorten the time of their 
fertility), concerns about an eventual pregnancy, risk of recurrence, concerns about work and 
career, body image concerns and sexuality concerns (Avis et al., 2005).  
Studies have also mentioned that age is relevant to social functioning and future 
perspective. Watters et al. (2003) found that future perspective was significantly better among 
older women with breast cancer than younger women with breast cancer. King et al. (2000) 
reported that younger women were more afraid of disease recurrence than older women were. 
Arndt et al. (2004) found that older breast cancer patients tended to report better role, 
emotional, cognitive and social functioning than younger women with breast cancer reported. 
10. Ethics  
When researchers work with data from human beings, they must know and follow all 
relevant ethical considerations (WMA, 1964). Thus, the present paper, discusses the ethics 
related to the empirical study that follows. First of all, I was not participating when collecting 
the data I used in this paper. Since I did not gain insight into the research protocol, I must 
trust that data was collected with the prescribed method. The treatment regimens were 
performed according to national guidelines (NBCG, 2012), so I have to trust that the sample 
is representative of the present group of patients in Norway. I obtained a copy of the 
certification from The Regional Committees for Medical Research Ethics (Appendix 4) which 
certifies that my research protocol and the plan used for data collection were approved. I also 
verified that all patients recruited for the main study had signed and given their written, 
informed consent before participating.  
All researchers studying human materials and data must preserve patient anonymity 
(WMA, 1964). In the main study database, the social security number for each informant had 
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been replaced with a PID-number. This procedure de-identified the data to protect the 
confidentiality of the informants before researchers could perform any analysis on the data.  
I would also like to reflect on the methodology I used for this master thesis. The 
analysis I chose for the next article might not be the most appropriate method for highlighting 
the aims of this study. Other analyses and methods that would clarify the aims of this study as 
well as I have done most likely exist. My lack of experience may influence the thoroughness 
of the chosen method as well as the paper in totality. Relevant findings and important factors 
in accordance to the aims of this study may have been overlooked. The findings of the present 
master thesis and a discussion appear toward the end of the empirical article.  
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Differences in HRQoL between younger and older women treated for 
breast cancer: Associations between social function, future perspective, 
body image, sexual function and QoL 
Katrine Salberg Jensen 
Department of Social Work and Health Science 
Norwegian University of Science and Technology (NTNU) 
Abstract 
Background: Breast cancer is the most common type of cancer among women in Norway, 
and development in screening and treatments have led to increasing survival rate both in 
younger and older women. More women are living with side effects after breast cancer, which 
have led to increasing focus on quality of life (QoL). Age-differences in aspects associated 
with QoL are assumed. Purpose: Earlier research has suggested that differences in age affects 
QoL aspects. In accordance to this, the aims of this study were: 1) to explore differences in 
QoL, social function, future perspective, body image and sexual function between younger (≤ 
50 years) and older (>50 years) women twelve months after treatment for breast cancer. 2) To 
identify associations between social function, future perspective, body image, sexual function 
and QoL among older and younger women treated for breast cancer. Methods: QoL and 
functional scales were measured by the European Organization for Research and Treatment of 
Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and the breast module QLQ-BR23. 
Independent t-tests and multiple regression analysis were performed in separated age-groups 
(young ≤ 50 years, old > 50 years). Results: Younger women reported significant lower body 
image than older women. Adjusted for comorbidity, surgery techniques and adjuvant 
treatments, social function (B= 0.66, p < 0.001) and sexual function (B= 0.20, p=0.020) were 
significantly associated with higher levels of QoL among younger women. In older women 
social function (B= 0.30, p < 0.001), sexual function (B= 0.19, p= 0.003) and future 
perspective (B= 0.27, p < 0.001) were significantly associated to QoL. Conclusions: The 
results highlight the importance of enhancing social and sexual functioning among women 
treated for breast cancer. Improvements in diagnosis and treatments have increased the rates 
of survival among breast cancer patients. Consequently, alternative approach to promote their 
health and QoL is highly essential. 
Key words: Breast cancer, Quality of Life, Health-Related Quality of Life, age-related 
differences.   
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1. Introduction 
Today, breast cancer is today the most common cancer in women worldwide (World 
Health Organization, 2012). In Norway, 2745 new breast cancer cases were recorded in 2009 
(Cancer Registry of Norway, 2011). Improvements in breast cancer treatments and 
mammography screening play an important role in the increasing rates of survival (Holleczek, 
Arndt, Stegmaier & Brenner, 2011). Women who survive breast cancer meet medical, 
physical and psychosocial challenges (Dizon, 2009). The subjective impact of this disease and 
this disease’s impairments and their treatments are the main concerns that the HRQoL 
addresses (Carr, Gibson & Robinson, 2001). Consequently, has this development led to 
increasing focus on quality of life (QoL) issues among breast cancer patients, and in research 
(Montazeri et al., 2008).  
Several aspects will change after a breast cancer diagnosis, and this change will, in 
turn, affect QoL. Parker et al. (2007), as well as other researchers, have found that women 
treated with mastectomy had poorer QoL scores than patients treated with breast conserving 
surgery. It is also well documented that patients treated with mastectomy have poorer sexual 
function, sexual enjoyment, body image and future perspective than patients treated with 
breast conserving surgery (Fobair et al., 2006; Kenny et al., 2000; King, Kenny, Shiell, Hall 
& Boyages 2000; Manganiello, Hoga, Reberte, Miranda & Rocha,  2011; Montazeri, 2008; 
Moyer, 1997; Munshi et al., 2010). Body image seems to be the aspect that is most strongly 
affected by type of surgery. Namely, women who received breast conserving surgery reported 
better body image than women treated with mastectomy (Curran et al., 1998; Figueiredo, 
Cullen, Hwang, Rowland & Mandelblatt 2004; Ganz, Cosacarelli Shag, Lee, Polinsky & Tan, 
1992; Hopwood, Haviland, Mills, Sumo & Bliss, 2007; Kenny et al., 2000; King et al., 2000; 
Montazeri, 2008). Changes in sexuality and intimacy depend on the woman’s psychological 
health and how she perceives herself (Hordern, 2000). In other words, body image may affect 
the sexuality of breast cancer patients.    
A breast cancer diagnosis can lead to impairment in several areas of a woman’s life, 
including social functioning (Preston, 2010). Visible problems may lead to avoidance of 
social situations (Harcourt & Frith, 2008). Watters, Yau, O’Rourke, Tomiak & Gertler (2003) 
found that physical, role and social functions decrease during breast cancer treatment such as 
chemotherapy. Further, improved social function has been shown in mastectomy patients 
(Munshi et al., 2010). A diagnose of cancer is likely to influence on future perspectives. 
Breast cancer patients may experience concerns about survival, risk of recurrence, premature 
menopause (which can lead to loss of fertility) and concerns about work, carrier, body image 
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and sexuality (Avis, Crawford & Manuel, 2005). Side effects after a breast cancer diagnosis 
can be numerous, so focusing on the aspects of health-related quality of life (HRQoL) seems 
essential.  
HRQoL is a comprehensive concept that includes factors like physical, emotional, 
sexual, social and cognitive functions as well as the symptoms of the disease and treatments. 
All of these factors are considered by and from the perspective of the patients (Bottomley & 
Therasse, 2002). In the present paper, the impact of HRQoL aspects such as body image, 
sexual function, social function and future perspective on overall QoL are interpreted and 
illustrated in a model. The model illustrates that all of the chosen HRQoL domains (social 
function, body image, sexual function and future perspective) are independent domains that 
are separated from the overall QoL but also contribute to the larger concept overall QoL.  
HRQoL in breast cancer patients has been shown to be dependent on age. Some found 
that older women (>50 years) tended to report better body image, social function, future 
perspective and overall QoL than younger women (≤ 50 years) reported (Arndt et al., 2004; 
Hopwood et al., 2007; King et al., 2000; Watters et al., 2003). Interestingly, other studies 
found that younger women had better QoL and sexual function than older women had (Arndt 
et al., 2004; Watters et al., 2003). Yet another group of researchers reported no significant 
difference in sexual dysfunction or body image in younger and older breast cancer patients 
(Wenzel et al., 1999). The results of HRQoL research among younger and older breast cancer 
patients still diverge. Nevertheless, age seems to be an important aspect of QoL discussions 
among women diagnosed with breast cancer.  
According this, the objective of this study was to explore HRQoL among younger and 
older women treated for breast cancer in Norway. The aims of the present study were:  
1) To explore differences in QoL, social function, future perspective, body image and 
sexual function between younger women (≤ 50 years) and older women (>50 years) twelve 
months after treatment for breast cancer; and  
2) To identify associations between social function, future perspective, body image, 
sexual function and the overall QoL among younger and older women, twelve months after 
treatment for breast cancer.  
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2. Patients and methods 
 
2.1. Sample and settings  
This empirical article draws upon data from a larger, prospective longitudinal study 
that investigated the side effects and health-related quality of life (HRQoL) after radiotherapy 
(RT) in breast cancer patients. Consecutive breast cancer patients were referred for 
postoperative RT at St.Olavs University Hospital in Trondheim, Norway. They provided oral 
and written information during their first meeting at the outpatient clinic. Inclusion criteria 
were 1) no metastatic disease, 2) no physical or psychological disorders that would interfere 
with participation and 3) the ability to speak and understand Norwegian. Patients who 
developed metastatic diseases during follow-up were excluded. The recruitment period was 
from February 2007 to October 2008. Out of 261 eligible patients, 250 (96%) agreed to 
participate. The recruitment procedure for the longitudinal study is published in 
Reidunsdatter, Rannestad, Frengen, Frykholm & Lundgren’s (2011) study. This main study’s 
assessments were performed before starting radiotherapy (RT), after ending RT and at three, 
six and twelve months after RT. During follow-ups, 10 patients were excluded due to 
metastatic disease (n=4) and patient requests (n=6). At the 12-month assessment, a total of 9 
patients were missing due to logistical problems (n=7) and unknown reasons (n=2). Hence, 
231 patients were available for analyses at this time point. 
 
2.2. Study design 
The present empirical work is based upon HRQoL data from the 12-month 
assessment, so this study’s design is cross-sectional.  
 
2.3. Measures 
All assessments were conducted as an outpatient follow-up at the hospital. Each 
patient’s oncologist registered clinical and treatment information at the first consultation and 
recorded it in an electronic database. Sociodemographic information was collected by a self-
report questionnaire when patients were included. “HRQoL measures” were assessed by the 
EORTC core QLQ-C30 questionnaire (Aaronson et al., 1993) and the breast module QLQ-
BR23 (Sprangers et al., 1996) at the 12-month consultation at the hospital.  
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QoL was assessed by the two-item “global health status/QoL” scale of the QLQ-C30 
core questionnaire. These two items address how patients rate their overall health and QoL 
during the past week on a 7-point response option from “very poor” (1) to “excellent” (7). 
Social function was assessed by the two items under the “social functioning” scale of 
the QLQ-C30. These items inquired whether the patient’s medical treatment or physical 
condition has interfered with family life or social activities during the past week.  
The functional scales of the breast module QLQ-BR23 were used to assess body 
image, sexual function and future perspective. The body image scale contains four items 
assessing whether the women have felt physically less attractive or less feminine as a result of 
their disease or treatment. In addition, the body image scale asked whether the women found 
it difficult to look at themselves naked and whether they had been dissatisfied with their body 
during the last week. Sexual functioning was assessed by two items asking to what degree the 
women have been sexually active and to what degree they have been interested in sexuality 
during the last four weeks. Future perspective is assessed by one item that asks to what degree 
the patients have been worried about their future health during the last week. The response 
options on all functional scales ranged from 1 to 4, where 1 represented “not at all”, 2 “a 
little”, 3 “quite a bit” and 4 “very much”. For detailed information regarding the wording of 
items, see the Norwegian questionnaires enclosed in Appendix 1-3.    
  Each scale was calculated for its average score and transformed to a percentile scale 
ranging from 0 – 100. Missing values were treated according to the scoring manual, which 
allows up to 50% missing observations per score. This means that the patient had to answer at 
least half of the items on the scale. In addition, the single-item measures were transformed 
into the same percentile scale. The transformation from raw score to percentile scale allowed 
the author to run more sophisticated analysis of the data. A high score represents a high level 
of functioning or high level of QoL (Aaronson et al., 1993).   
 
Background variables  
This paper used the following socio-demographic and clinical variables as its 
background variables: age, marital status, type of surgery, chemotherapy, radiotherapy, 
hormone therapy and comorbidity. All of the control variables were dichotomized. Age was 
dichotomized as ≤ 50 years and >50 years to serve as an approximate indicator of menopausal 
status. This cut-off point is used in several QoL breast cancer studies (Avis et al., 2005; 
Burwell, Case, Kaelin & Avis, 2006; Fehlauer, Tribius, Mehnert & Rades, 2005; Fobair et al., 
2006; Kerr, Engel, Schlesinger-Raab, Sauer & Hölzer, 2003; Park, Lee, Lee, Lee & Hwang, 
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2011; Wenzel et al., 1999; Wong-Kim & Bloom, 2005) as well as epidemiologic literature 
(Morabia & Costanza, 1998).  
Marital status was coded into “recluse” (0) or “married/cohabitant” (1), and type of 
surgery was coded into “breast conserving surgery” (0) or “mastectomy” (1). The different 
kinds of adjuvant therapies - chemotherapy, radiation therapy and hormone therapy - were all 
dichotomized into “no” (0) or “yes” (1). Comorbidity was defined as having one or more of 
these chronic conditions: cardiovascular disease, pulmonary disorders, diabetes or depression, 
and was dichotomized into “yes” and “no” (having non comorbidities). 
 
2.4. Statistical analyses  
Statistical analyses were carried out using IBM SPSS Statistics Data Editor 19.0 for 
Windows. Descriptive statistics were used to analyze the socio-demographic data and clinical 
characteristics of the study sample. Chi-square tests were used to identify significant 
differences in categorical socio-demographic and clinical characteristics between the two age 
groups. The internal consistency of the questionnaires was assessed by estimating the 
Cronbach’s alpha (α) values of the multi-item scales based on the recommendation of > 0.70 
(Ringdal, 2007).  
Means and standard deviations (SDs) were calculated for the continuous variables of 
QoL, body image, sexual function, future perspective and social function. Further, the 
association between the independent variables’ scale score and QoL, socio-demographic and 
clinical variables, were analyzed by using Pearson’s correlations.  
To test differences in the two age groups within the variables body image, sexual 
function, future perspective, social function and QoL, t-tests for independent samples were 
used. Statistical significance was set to p < 0.05. 
A multiple regression analysis was used to assess the association between the 
dependent variable, QoL, and the independent variables of body image, sexual functioning, 
future perspective and social function. With QoL as the dependent variable, the independent 
variables were entered in blocks in the following order. In the first step, the background 
variables (marital status, surgery, chemotherapy, hormone therapy, radiotherapy and 
comorbidity) were entered. Thereafter, the continuous variables were entered. Body image 
was entered in step two, social function in step three, future perspective in step four and 
sexual function in step five. The multiple R
2
 coefficients were used to estimate the percentage 
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of variability of the dependent variable, accounted for all the independent variables in the 
regression models.  
3. Ethics  
 Every patient that the main study recruited had signed and given her written, informed 
consent. The institutional review board, The Regional Committees for Medical Research 
Ethics and The Data Inspectorate approved the main study. The author’s application to carry 
out the present empirical work was approved by The Regional Committees for Medical 
Research Ethics (Appendix 4).  
  
 39 
 
4. Results 
4.1. Participants 
The socio-demographic and clinical characteristics of the two age groups appear in 
Table 1. The patient’s ages ranged from 28 years to 89 years, and the mean age was 58 years. 
78.8% of the sample was >50 years old.  
There was no significant difference in marital status between the two age groups (p = 
0.417). The majority of the women in both age groups were married/cohabitant: 81.3% of the 
younger women and 75.7% of the older women. A significantly larger proportion of younger 
women had removed the breast (p = 0.002) and received chemotherapy (p < 0.001) compared 
to the older women. Comorbidity was reported significantly more often among older women 
(p = 0.038) than among younger women.  
 
Table 1. Differences in socio-demographic and clinical characteristics in the two age-groups.  
Age 
Demographic and 
clinical variables 
     ≤ 50 years old, n=49 
n (%) 
    >50 years old, n=182 
n (%) 
Total, n=231 
n (%) 
Marital status     
Married/cohabitant 
     Recluse 
 
39 (81.3) 
  9 (18.8) 
 
137 (75.7) 
  44 (24.3) 
 
176 (76.9) 
53 (23.1) 
Surgery 
** 
    Mastectomy                          
    Breast conservation 
 
 
22 (44.9) 
27 (55.1) 
 
   
42 (23.1) 
140 (76.9) 
 
  
 64 (27.7) 
167 (72.3) 
 
Radiotherapy  49 (100) 182 (100) 
 
231 (100) 
 
Chemotherapy 
*** 
45 (91.8) 51 (28) 
 
96 (41.6) 
 
Hormone therapy 
 
Comorbidity 
* 
28 (57.1) 
 
  6 (12.2) 
98 (53.8) 
 
48 (26.4) 
126 (54.5) 
 
  54 (23.4) 
 
*p < 0.05 (2- tailed)           ** p < 0.01 (2-tailed)         *** p < 0.001 (2-tailed) 
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4.2. Descriptive statistics  
The internal consistency was good and significant for all scales: it was α = 0.90 for the 
QoL scale, α = 0.90 for the body image scale, α = 0. 91 for the sexual function scale and α = 
0.85 for the social function scale.     
Tables 2 and 3 display the Pearson’s correlation coefficients between the study 
variables separated by age group. Significant correlations were found between QoL and other 
variables in both age groups (≤ 50 years and > 50 years). Among younger women, QoL was 
significant (< 0.05) and positively correlated with marital status, body image, sexual function 
and future perspective. All were medium-strong correlations. Furthermore, QoL was 
significant (< 0.01) and positively correlated with social function (strong correlation) in this 
age group.  
Among older women, QoL was significant (< 0.01) and positively correlated with 
body image (medium-strong correlation), sexual function (medium-strong correlation), future 
perspective (strong correlation) and social function (strong correlation). QoL was also 
significant (< 0.01) and negatively correlated with surgery (weak correlation), comorbidity 
(weak correlation). QoL significantly correlated (< 0.05) with hormone therapy (weak 
correlation). Among the younger women, the strongest correlation was observed between 
QoL and social function; among older women, the strongest correlations were observed 
between QoL and future perspective, as well as QoL and social function.   
 
 
 41 
 
Table 2. Pearson correlations coefficients of the study variables among younger (≤ 50 years old) women (n= 49). 
*p < 0.05 (2- tailed)           ** p < 0.01 (2-tailed) 
 
 
 
 
 
 
      1          2        3     4      5                                    6 7       8       9   10    11  
Age ≤ 50 
             
1. Surgery  -     -            
2. Chemotherapy  0.27  -           
3. Hormone therapy   0.04    0.35*  -          
4. Radiotherapy   0.60**    0.32*  0.01  -         
5. Comorbidity  0.16    0   0.11 0.07 0.23 -        
6. Marital status  0.10   0.05 0.01   0.  0.07 -0.14 -       
7. Quality of Life  0.05   -0  -0.07 0.04  -0. -0.11 -0.12  0.29* -      
8. Body Image  -0.28* -0.16 0.09             -0 -0.37** -0.16   0.38** 0.33*  -     
9. Sexual Function  0.16   0.03 0.03 0.06   0.01 0.36*  0.34*  0.12  -    
10. 10.Future Perspective -0.09  -0.03 0.15   -0. -0.13  -0.05   0. 0.26  0.28
* 
  0.41
**
  0.01          -   
11. Social Function  -0.22 -0.08 0.08 -0.35
* 
 -0.31
* 
  0.39
** 
  0.66
** 
  0.44
**
  0.13      0.19 -   
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Table 3. Pearson correlations coefficients of the study variables among older (>50 years old) women (n= 182).  
*p < 0.05 (2- tailed)           ** p < 0.01 (2-tailed)                                               
 
                   
 
 
 
 
     1      2       3         4        5        6        7        8         
 
9      10   11  
Age >50 
            
1. Surgery     -            
2. Chemotherapy  0.30
**
       -           
3. Hormone therapy  0.38
**
    0.16
*
 -          
4. Radiotherapy  0.49
**
    0.36
**
  0.49
**
 -         
5. Comorbidity   0.15
*
    0.02     0.10 0.01 -        
6. Marital status   -0.09    0.04    -0.11 -0.01 -0.07 -       
7. Quality of Life  -0.19
**
   -0.06     -0.17
*
    -0.11   -0.20
**
 0.04 -      
8. Body Image  -0.40
**
   -0.22
**
 -0.29
**
   -0.37
**
 -0.03 0.02  0.36
**
 -     
9. Sexual Function  -0.20
*
    0.03    -0.12    -0.11   -0.21
**
    0.33
**
  0.33
**
  0.21
**
      -    
10. Future Perspective   -0.19
*
   -0.16
*
 -0.19
*
  -0.19
**
  -0.18
*
 -0.07  0.56
**
  0.53
**
  0.21
**
     -    
11.  Social Function  -0.11   -0.14    -0.13    -0.16* -0.13 -0.01  0.55**  0.40**   0.11 0.54**   -  
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4.3. Age -specific scores  
The independent-sample t-test showed a significant difference between younger and 
older women in body image, t (224) = 2.25, p < 0.05, but not in any of the other variables. 
Older women experienced more positive body image (M = 88.28, SD = 18.13) than younger 
women (M = 81.12, SD = 24.58).  
Table 4 displays means and standard deviations (SDs). The mean values were quite 
similar between younger and older women, with the exception of the mean values for future 
perspective, sexual function and body image. On future perspective and body image, older 
women scored higher (future perspective M=71.98, body image M=88.28) than younger 
women did (future perspective M=64.63, body image M=81.12). On sexual function, younger 
women (M=35.71) scored higher than older women did (M=28.74). Body image and social 
function were the variables with the highest reported mean scores in both age groups. After 
calculating these values, there was interesting to see whether any of the independent variables 
were associated with the dependent variable, QoL. 
 
Table 4. Comparison of mean scores between younger (≤ 50 years) and older (>50 years) 
women treated for breast cancer, twelve months after treatment.  
 
Variables 
≤ 50 years old 
n=49 
         Mean (SD) 
>50 years old 
      n=182 
Mean (SD) 
 
 
Quality of Life        79.42 (17.69) 75.23 (21.71)              
Body image 
*        81.12 (24.58) 88.28 (18.13)  
Sexual function        35.71 (25.23) 28.74 (23.26)  
Future perspective        64.63 (24.91) 71.00 (27.06)  
Social function        82.65 (19.53) 84.53 (23.11)  
* 
p < 0.05  
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4.4. Associations between independent variables and QoL 
A linear hierarchical multiple regression analysis was used to explore whether any of 
the independent variables had any association with the dependent variable, QoL, separated in 
age groups (≤ 50 years and > 50 years). These results are shown in Table 5.  
 
Table 5. Linear hierarchical multiple regression analysis. Associations to QoL in younger (≤ 
50 years old) and older (> 50 years old) women treated for breast cancer in Norway.  
                                                 Women ≤ 50 years old                   Women > 50 years old  
                 (n=49)    (n=182)  
Step and variable    B        R
2
   B      R
2
   
 
Step 1             
Control variables:    
  Marital status           13.02             0.21 
  Surgery              5.60            -6.54 
  Chemotherapy            -4.99            -0.79 
  Hormone therapy             2.29            -2.64 
  Radiotherapy             -6.85            -2.13 
       Comorbidity            -3.19            -9.25 
                   0.13               0.08   
Step 2            
 Body Image             0.04 0.04          -0.04
 
          0.09 
Step 3            
 Social function            0.66
***
 0.33
***  
         0.30
*** 
      0.17
*** 
Step 4            
 Future perspective                        0.13 0.02           0.27
***
       0.07
*** 
Step 5            
Sexual function            0.20
*
 0.07
*
           0.19
**
    0.03
** 
 
*p< 0.05; **p< 0.01;  ***p< 0.001. Overall R
2 
= 0.48 (48%) in the age group ≤ 50 years old, and overall R2 = 
0.41 (41%) in the age group > 50 years old.       R
2
 = R
2
 Change.  
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According to the multiple regression analysis, none of the background variables 
(marital status, surgery, chemotherapy, hormone therapy, radiotherapy and comorbidity) 
emerged to be significantly associated with QoL. After adjusting for the background 
variables, social functioning (B= 0.66, p < 0.001) and sexual functioning (B= 0.20, p=0.020) 
were significantly associated with higher levels of QoL among younger women. In older 
women, social function (B= 0.30, p < 0.001), sexual function (B= 0.19, p= 0.003) and future 
perspective (B= 0.27, p < 0.001) were significantly associated with QoL. Furthermore, future 
perspective (B= 0.13, p= 0.142) was not significantly associated with QoL in younger 
women, and neither was body image (B= 0.04, p= 0.715). Likewise, body image in older 
women (B= -0.4, p= 0.706) was not significantly associated with QoL.   
Among the older women, social function explained 33% of the variance in QoL, and 
sexual function explained 7% of the variance in QoL. In the younger age group, social 
function explained 17% of the variance in QoL, sexual function explained 3% of the variance 
and future perspective explained 7% of the variance in QoL. The overall R
2
 for the regression 
model among women aged ≤ 50 years old was 0.48 (48%), and the total R2 for women aged 
>50 years old was 0.41 (41%). In other words, the regression models explain 48% and 41% of 
the variance in QoL among younger and older women respectively, at twelve months after 
treatment for breast cancer.   
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5. Discussion  
HRQoL has become an essential outcome measure of the treatment of cancer patients 
(Arndt et al., 2004). Although treatment techniques and early detection have improved the 
survivor rates, breast cancer may still affect the QoL of women (Montazeri, 2008). The aims 
of this study were 1) to explore differences in QoL, social function, future perspective, body 
image and sexual function between younger (≤ 50 years) and older (>50 years) women twelve 
months after treatment for breast cancer and 2) to identify associations between social 
function, future perspective, body image, sexual function and the QoL among younger and 
older women treated for breast cancer. 
The present study found that older women (>50 years) experienced significantly better 
body image than younger women (≤ 50 years). This means that breast cancer seems to affect 
body image among older women less than it affects body image among younger women. 
These findings are similar with the results presented by Hopwood et al. (2007) and King et al. 
(2000). They also found that older women (>50 years) on average had better body image than 
younger women (≤ 50 years) had. These findings suggest that practitioners should anticipate 
providing more support for body image to their younger patients than to their older ones. One 
potential explanation for the difference in body image can be type of surgery. Earlier reports 
have documented that women who underwent breast conserving surgery reported fewer 
problems with body image than those who had to remove the breast (Kenny et al., 2000). In 
our sample, only 22.8% of older women underwent mastectomy, while this proportion was 
the double (45.6%) in younger women, so this could be a plausible explanation of the 
difference in body image. The link between psychological distress, body image problems and 
having a mastectomy can indicate the essence of the biopsychosocial model, because the body 
and the mind are connected in this model (Dizon, 2009). 
In the present sample, 91.8% of the younger women received chemotherapy, while 
only 28% of the older women underwent this type of adjuvant treatment. The breast cancer 
disease is often more aggressive in younger women than it is in older women. Consequently, 
younger women normally receive more intensive adjuvant treatment, and this greater intensity 
is likely to result in more side effects in younger patients (Wenzel et al., 1999). Fatigue is the 
most frequently reported side effect among breast cancer patients, and can often last for years 
after the end of treatment (Bower et al., 2000). Fatigue is known to influence many 
dimensions of life, such as social function and sexual function (Bower et al., 2000; Henson, 
2002). Therefore, the poorer body image among the younger population could also be 
attributed to the more intensive treatment. 
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The identity theory might also throw light over the poorer body image experienced by 
younger women. The breasts mean a lot to women’s self-image, and they are a symbol of 
femininity and sexuality (Kåresen, Schlichting & Wist, 1998). Loss of a breast and poorer 
body image can make women feel less feminine and thereby have a considerable impact on 
their identity. One might suppose that identity is stronger in older women, so younger women 
are more vulnerable to such loss.  
Despite the difference in body image among younger and older women, neither of the 
age groups associates body image significantly with QoL. Therefore, it is possible that other 
dimensions of HRQoL are more important to the QoL among women in this study. This result 
might also be explained by the different number of informants in each age group. The small 
sample size in the group aged ≤ 50 years could have caused a lack of sufficient statistical 
power in this group, which may further affect the results.  
The present study found no significant differences in QoL, sexual function, future 
perspective and social function between younger and older women twelve months after 
treatment for breast cancer. Earlier studies do not support the present findings, as differences 
between younger and older women have been found for these HRQoL aspects (Andt et al., 
2004; King et al., 2000; Park et al., 2011; Watters et al., 2003; Wenzel et al., 1999). Some 
previous studies found that older women (>50 years) tended to report better body image, 
social function, future perspective and overall QoL than younger women (≤ 50 years) reported 
(Arndt et al., 2004; Hopwood et al., 2007; King et al., 2000; Watters et al., 2003). Others 
reported that younger women had better QoL and sexual function than older women had 
(Arndt et al., 2004; Watters et al., 2003). A third reported no significant difference in sexual 
dysfunction between the younger and older breast cancer patients (Wenzel et al., 1999), which 
supports the present findings in this study. These differing results could be explained by 
methodical aspects. The sample size in the group ≤ 50 years old was small compared to the 
sample size or the age group >50 years. This might cause a lack of sufficient statistical power 
in the group younger group, which could have led to no significant differences between 
younger and older women in these HRQoL aspects. 
Despite these findings, social function, sexual function and future perspective were 
significantly associated with QoL. Social function and sexual function were significantly 
associated with QoL among younger women, while social function, sexual function and future 
perspective were significantly associated with QoL among older women in this study. Social 
function seems to be an important aspect to one’s QoL among both younger and older women 
in this sample. By focusing on, and offering good and confident social support to women 
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treated for breast cancer, health professional may help their patients to improve their social 
function and ultimately their QoL. Previous research offers mixed support for the present 
results. Some studies found that sexual function and social function are associated with QoL 
outcome in breast cancer patients (Mols et al., 2005; Montazeri et al., 2008; Pikler & 
Winterowd, 2003; Sammarco, 2009), whereas others did not find any association between 
social function, sexual function, future perspective and QoL (Safaee et al., 2008; Saleha et al., 
2010).  
Although social and sexual functions are associated with QoL in both younger and 
older women, they can differ in gradation. The social function seems to have less impact on 
the QoL of older women than it does on the QoL of younger women. Social function in 
younger women may be more important for their QoL than among older women, due to their 
family situations. Namely, younger women are likely to have young children, who still need 
support, help and care from their mother. The age of their family members may therefore 
present a plausible explanation for the difference. Nevertheless, both age groups reported that 
social function is the most important factor of QoL. Participating in social activities and 
intercourse with friends is probably essential to a human, regardless of age. One of the most 
fundamental human motivations is described as the need to form interpersonal connections 
and the need to serve a function in society (Preston, 2010). These fundamental human 
motivations may highlight why social function explains so much of the variance in QoL in the 
present sample. 
The results presented in this paper also indicate that sexual function is significantly 
associated with QoL in both younger and older women. Sheppard and Ely (2008) have shown 
that sexuality is central to a person’s sense of wellness and self-concept, so it may be an 
important aspect to follow, maintain and promote. Sexual function explains the variance in 
QoL among younger women better than it explains the variance among older women, which 
might be natural. It is reasonable to believe that younger women are more sexually active than 
older women. The other side of this assumption about younger women is the assumption that 
older women tend to loose interest in sexuality. As a result, society often ignores the sexual 
needs of older people (Hordern, 2000). Sexuality is described as a deep and integral aspect of 
the human personality and as an important aspect in a relationship (Sheppard & Ely, 2008). 
According this, the majority of the present sample is married/recluse, which can be a plausible 
explanation for the significant association between sexual function and QoL. According these 
findings, there is important focusing on sexuality among both younger and older breast cancer 
patients. Most oncologist and health personnel treating breast cancer patients probably need to 
 50 
 
gain more knowledge about this aspect and then inform their patients. A wider dissemination 
of knowledge about the importance and the effects of sexual function would probably 
promote QoL in breast cancer patients.   
Future perspective also appeared as significantly associated with QoL among older 
women in this sample but not among younger women. The reason for this might be age 
differences. Different kinds of considerations may appear in accordance with thoughts about 
the future and the future perspective, and age may influence which kind of considerations the 
patient will have (Dizon, 2009). The reason for this difference might also be methodical. 
Again, the sample size of each age group is not equal. The small sample size in the age group 
≤ 50 years can cause a lack of sufficient statistical power to detect a possible association in 
this group. Further, the disparity in size might affect several results in this paper. Perhaps a 
different cut-off point in age would have been more pragmatic and led to other results. 
Despite the number of group members, the respective cut-off point was used to serve as an 
approximate indicator of menopausal status, and this cut-off point is used in several QoL 
breast cancer studies (Avis et al., 2005; Burwell et al., 2006; Fehlauer et al., 2005; Fobair et 
al., 2006; Kerr et al., 2003; Park et al., 2011; Wenzel et al., 1999; Wong-Kim & Bloom, 2005) 
as well as epidemiologic literature (Morabia & Costanza, 1998).  
 
5.1. Strengths and limitations 
Interpretation and discussion of this data must consider some limitations. First of all, 
this study may be limited demographically, because it is based on a selective sample of 
patients from only one hospital in Norway. It can be difficult to generalize with this selective 
sample. This sample may not reflect differences in younger and older women and aspects 
associated with QoL in other areas of the country. The advantage of this sample is that it 
consists of breast cancer patients in different age groups, which makes this sample relatively 
varied. 
Another aspect that can limit this study is the chosen time of measurement. Only one 
measurement time was explored, which was twelve months after breast cancer treatment. This 
cross-sectional design makes it impossible to explore cause- effect relationships. However, 
the choice to study only one time was made in accordance to the scope and the aims of this 
paper.           
 Despite these limitations, this study has several important strengths. It has a relatively 
large sample size (N=231), patients ranging from 28 to 89 years of age, and it looks at both 
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younger and older women with breast cancer. Women of all ages may get a breast cancer 
diagnosis, so research among both younger and older women is important. Further, a wide 
range of ages allows researchers to compare age groups and to run more analyses. 
 
5.2. Conclusion  
In conclusion, improvements in diagnosis and treatments have increased the rates of 
survival among breast cancer patients. Consequently, alternative approaches to promoting 
their health and QoL are essential. This research suggests that younger breast cancer patients 
have greater difficulties with altered body image than older women do at twelve months after 
treatment for breast cancer. The impact of social function, sexual function and future 
perspective on QoL appears to be the most important factors among women in the present 
sample. The results highlight the importance of enhancing social and sexual functioning 
among both younger and older women. During breast cancer treatment as well as at follow-
up, personnel should focus on helping the patient to maintain adequate social support. 
Encouraging the patient to participate in social activities and family life may likely be a good 
technique during the whole illness process for any woman, regardless of age. Health care 
professionals and clinicians treating breast cancer patients should be aware of the need for 
open discussion of sexual concerns and worries, from both younger and older patients. 
Furthermore, professionals should be prepared to offer support, guidance and counseling 
(Henson, 2002). In addition, good oral and written information about sexuality in breast 
cancer should probably be given before treatment and during treatment. In general, preparing 
both younger and older women for the age-related impact of breast cancer and helping them 
to deal with their problems may improve their QoL. However, there is a need for more 
research to complete the knowledge of this comprehensive field. Despite the enormous 
amount of literature already published for this field, none of the extant studies clarify exactly 
what factors affect QoL the most among breast cancer patients. More research should be 
performed, and data from comparable groups of women without breast cancer might be 
interesting to explore in comparison. Such a comparison could help us to investigate whether 
there exist any differences between breast cancer patients and healthy women according to the 
aspects associated with QoL.   
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